| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2021-09-14 15:44:40 UTC |
|---|
| HMDB ID | HMDB0000481 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Allopurinol riboside |
|---|
| Description | Allopurinol is an analog of the natural purines in the body, and is quickly metabolized to oxypurines which is also a xanthine oxidase inhibitor. Allopurinol is a white, powdery drug used to treat gout. Its use in the United States was started in 1964. It is an isomer of hypoxanthine and inhibits the production of uric acid, the metabolite responsible for gout, by inhibiting the enzyme xanthine oxidase. The side effects of high levels of precursors are usually minor. A small percentage of people develop a rash and must discontinue this drug. The most serious adverse event is a hypersensitivity syndrome consisting of fever, skin rash, eosinophilia, hepatitis, and worsening renal function. In some cases, allopurinol hypersensitivity syndrome. |
|---|
| Structure | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1N=CC2=C1NC=NC2=O InChI=1S/C10H12N4O5/c15-2-5-6(16)7(17)10(19-5)14-8-4(1-13-14)9(18)12-3-11-8/h1,3,5-7,10,15-17H,2H2,(H,11,12,18)/t5-,6-,7-,10-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Hydroxy[3,4-D]pyrazolopyrimidine riboside | ChEBI | | Allopurinol ribonucleoside | ChEBI | | Allopurinol-1-ribonucleoside | ChEBI |
|
|---|
| Chemical Formula | C10H12N4O5 |
|---|
| Average Molecular Weight | 268.2261 |
|---|
| Monoisotopic Molecular Weight | 268.080769514 |
|---|
| IUPAC Name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one |
|---|
| Traditional Name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-pyrazolo[3,4-d]pyrimidin-4-one |
|---|
| CAS Registry Number | 16220-07-8 |
|---|
| SMILES | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1N=CC2=C1NC=NC2=O |
|---|
| InChI Identifier | InChI=1S/C10H12N4O5/c15-2-5-6(16)7(17)10(19-5)14-8-4(1-13-14)9(18)12-3-11-8/h1,3,5-7,10,15-17H,2H2,(H,11,12,18)/t5-,6-,7-,10-/m1/s1 |
|---|
| InChI Key | KFQUAMTWOJHPEJ-DAGMQNCNSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pyrazolo[3,4-d]pyrimidine glycosides. These are nucleosides or derivatives thereof that consist of a pyazolo[3,2-d]pyrimidine ring system that is N-glycosidically linked to a ribose or deoxyribose. They bear the sugar moiety on the pyrimidine part of the molecule. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Nucleosides, nucleotides, and analogues |
|---|
| Class | Pyrazolo[3,4-d]pyrimidine glycosides |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Pyrazolo[3,4-d]pyrimidine glycosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyrazolo[3,4-d]pyrimidine glycoside
- Glycosyl compound
- N-glycosyl compound
- Pentose monosaccharide
- Pyrazolo[3,4-d]pyrimidine
- Pyrazolopyrimidine
- Pyrimidone
- Monosaccharide
- Pyrimidine
- Azole
- Heteroaromatic compound
- Pyrazole
- Vinylogous amide
- Tetrahydrofuran
- Secondary alcohol
- Organoheterocyclic compound
- Azacycle
- Oxacycle
- Primary alcohol
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.92 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.1341 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.22 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 185.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 627.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 246.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 61.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 160.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 50.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 299.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 257.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 667.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 568.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 57.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 764.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 177.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 205.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 606.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 377.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 303.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Allopurinol riboside,1TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@H](O)[C@@H]1O | 2543.7 | Semi standard non polar | 33892256 | | Allopurinol riboside,1TMS,isomer #2 | C[Si](C)(C)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CC2=C1[NH]C=NC2=O | 2547.0 | Semi standard non polar | 33892256 | | Allopurinol riboside,1TMS,isomer #3 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@@H]1O | 2556.0 | Semi standard non polar | 33892256 | | Allopurinol riboside,1TMS,isomer #4 | C[Si](C)(C)N1C=NC(=O)C2=C1N([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)N=C2 | 2642.8 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@H](O[Si](C)(C)C)[C@@H]1O | 2517.8 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TMS,isomer #2 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@H](O)[C@@H]1O[Si](C)(C)C | 2523.2 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TMS,isomer #3 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C)C=NC3=O)[C@H](O)[C@@H]1O | 2624.7 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TMS,isomer #4 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@@H]1O[Si](C)(C)C | 2537.1 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TMS,isomer #5 | C[Si](C)(C)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CC2=C1N([Si](C)(C)C)C=NC2=O | 2641.8 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TMS,isomer #6 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2N=CC3=C2N([Si](C)(C)C)C=NC3=O)[C@@H]1O | 2645.5 | Semi standard non polar | 33892256 | | Allopurinol riboside,3TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2522.7 | Semi standard non polar | 33892256 | | Allopurinol riboside,3TMS,isomer #2 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C)C=NC3=O)[C@H](O[Si](C)(C)C)[C@@H]1O | 2628.5 | Semi standard non polar | 33892256 | | Allopurinol riboside,3TMS,isomer #3 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C)C=NC3=O)[C@H](O)[C@@H]1O[Si](C)(C)C | 2621.0 | Semi standard non polar | 33892256 | | Allopurinol riboside,3TMS,isomer #4 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2N=CC3=C2N([Si](C)(C)C)C=NC3=O)[C@@H]1O[Si](C)(C)C | 2641.2 | Semi standard non polar | 33892256 | | Allopurinol riboside,4TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C)C=NC3=O)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2652.6 | Semi standard non polar | 33892256 | | Allopurinol riboside,4TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C)C=NC3=O)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2904.9 | Standard non polar | 33892256 | | Allopurinol riboside,4TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C)C=NC3=O)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 3122.0 | Standard polar | 33892256 | | Allopurinol riboside,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@H](O)[C@@H]1O | 2789.8 | Semi standard non polar | 33892256 | | Allopurinol riboside,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CC2=C1[NH]C=NC2=O | 2791.8 | Semi standard non polar | 33892256 | | Allopurinol riboside,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@@H]1O | 2800.0 | Semi standard non polar | 33892256 | | Allopurinol riboside,1TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N1C=NC(=O)C2=C1N([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)N=C2 | 2897.6 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 2990.3 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2995.6 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)[C@H](O)[C@@H]1O | 3083.8 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2986.9 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CC2=C1N([Si](C)(C)C(C)(C)C)C=NC2=O | 3081.1 | Semi standard non polar | 33892256 | | Allopurinol riboside,2TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2N=CC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)[C@@H]1O | 3086.7 | Semi standard non polar | 33892256 | | Allopurinol riboside,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2[NH]C=NC3=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3181.8 | Semi standard non polar | 33892256 | | Allopurinol riboside,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 3282.5 | Semi standard non polar | 33892256 | | Allopurinol riboside,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 3277.4 | Semi standard non polar | 33892256 | | Allopurinol riboside,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2N=CC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)[C@@H]1O[Si](C)(C)C(C)(C)C | 3281.8 | Semi standard non polar | 33892256 | | Allopurinol riboside,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3444.3 | Semi standard non polar | 33892256 | | Allopurinol riboside,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3635.7 | Standard non polar | 33892256 | | Allopurinol riboside,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2N=CC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3443.4 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (Non-derivatized) - 70eV, Positive | splash10-0adl-9230000000-f2b42573dba0039df9fc | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (3 TMS) - 70eV, Positive | splash10-0gir-5955300000-84fcb654b6b0639a529b | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Allopurinol riboside GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 10V, Positive-QTOF | splash10-000i-0920000000-a9fa0dd7e6fa50ea6984 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 20V, Positive-QTOF | splash10-000i-0900000000-21c7b658689fb9512f0b | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 40V, Positive-QTOF | splash10-052r-1900000000-a0d5d35743edd0e2288b | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 10V, Negative-QTOF | splash10-000i-0900000000-ab1c150a018c7c95cfcf | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 20V, Negative-QTOF | splash10-000i-0900000000-c23b7002c1cf46d80397 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 40V, Negative-QTOF | splash10-0a4r-4900000000-94845c316294342528a8 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 10V, Negative-QTOF | splash10-014j-0290000000-1fe2c9a9f3ca1ec73a39 | 2021-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 20V, Negative-QTOF | splash10-000i-0900000000-dc2d53701ff620e1a6e4 | 2021-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 40V, Negative-QTOF | splash10-000i-4900000000-32ca35fb23ae98d9baef | 2021-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 10V, Positive-QTOF | splash10-000i-0910000000-8f996cedd72f2106a9ba | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 20V, Positive-QTOF | splash10-000i-0900000000-2fcf648123cc944c1522 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopurinol riboside 40V, Positive-QTOF | splash10-000i-2900000000-36c56b92eacd3d7ca10d | 2021-09-25 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
|
|---|